Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-07Clinical Trial Update: Evaluating an Alternative Clinical Genetics Cancer Care Delivery Model: A Pilot Study of Patient Outcomes
Memorial Sloan Kettering Cancer Center is piloting an alternative genetics-based cancer care delivery model and assessing patient outcomes; …
-
CLINICAL_TRIALS research · 2025-10-06Clinical Trial Update: Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating atezolizumab in combination with BDB001 and immunogenic radiotherapy for advanced solid tumors is currentl…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: AG Followed by FOLFIRINOX Both Combined With PD-L1 Antibodies as a Conversion Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer. [Phase 2]
Phase 2 clinical trial evaluating AG followed by FOLFIRINOX with a PD-L1 antibody as conversion therapy for borderline resectable and locall…
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
This clinical trial protocol from the University of Nottingham aims to characterize biliary strictures and hepatobiliary–pancreatic focal le…
-
CLINICAL_TRIALS other · 2025-10-03Clinical Trial Update: Multidom Remote Monitoring of Patient With Advanced Pancreatic Cancer Treated With Florinox Using the PiCaDo Plateform [NA]
This clinical trial update notes the completed status of a remote monitoring study involving a patient with advanced pancreatic cancer treat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-10-02Clinical Trial Update: CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors [Phase 1]
This update covers a Phase 1 trial of a CAR-T therapy targeting carcinoembryonic antigen (CEA) for CEA-positive advanced solid tumors, curre…
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: A Study of ABTL0812 in Pancreatic Cancer [Phase 1, Phase 2]
The ABTL0812 pancreatic cancer trial (Phase 1/Phase 2) is suspended.
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer [Phase 2]
Phase 2 clinical trial exploring losartan and nivolumab with FOLFIRINOX and SBRT for localized pancreatic cancer; currently active but not r…
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
University of Chicago is recruiting for a tissue procurement study across multiple cancers in patients undergoing surgery or biopsy to colle…
-
CLINICAL_TRIALS trial_result · 2025-09-30Clinical Trial Update: Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer [Phase 1, Phase 2]
This completed Phase 1/2 study evaluated the safety and tolerability of combining epigenetic and immunomodulating drugs with standard chemot…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: A Single-Arm Investigator-Initiated Tria (IIT) Evaluating the Safety and Preliminary Efficacy of Autologous Drug-Loaded Neutrophils (NeuMed) in Patients With Unresectable Pancreatic Cancer [EARLY_Phase 1]
This document reports on a single-arm investigator-initiated Phase 1 trial evaluating autologous drug-loaded neutrophils (NeuMed) in patient…
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer [NA]
The ToPanc trial is evaluating survival after total versus partial pancreaticoduodenectomy for pancreatic head adenocarcinoma, distal cholan…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic Cancer
An individual patient expanded access IND for Hope Biosciences' HB-adMSCs (allogeneic adipose-derived mesenchymal stem cells) to treat pancr…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Pilot Study of Ciprofloxacin Plus Gemcitabine and Nab-Paclitaxel Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma. [Phase 1]
Phase 1 clinical trial update on combining ciprofloxacin with gemcitabine and nab-paclitaxel for metastatic pancreatic cancer; the study is …
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Patient-derived Organoids Drug Screen in Pancreatic Cancer [NA]
The study completed a patient-derived pancreatic tumor organoids drug-screen to evaluate potential drug responses.
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) [Phase 1, Phase 2]
This clinical trial update reports Eli Lilly's KRAS G12C inhibitor LY3537982 is being studied in Phase 1/2 trials across multiple KRAS G12C-…
-
CLINICAL_TRIALS trial_result · 2025-09-24Clinical Trial Update: A Dose Escalation Study of HBI-2438 in Patients With Solid Tumors Harboring KRAS G12C Mutation [Phase 1]
Phase 1 dose-escalation study of HBI-2438 in KRAS G12C-mutant solid tumors; the trial is active but not recruiting and targets indications i…
-
CLINICAL_TRIALS research · 2025-09-24Clinical Trial Update: A Dose Escalation Study of SHP2 Inhibitor in Patients With Solid Tumors Harboring KRAS of EGFR Mutations [Phase 1]
A Phase 1 dose-escalation trial of an SHP2 inhibitor in patients with solid tumors harboring KRAS or EGFR mutations is currently active and …
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: HRS-4642 With Nimotuzumab and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer Patients [Phase 2]
A Phase 2 clinical trial evaluating HRS-4642 in combination with nimotuzumab and chemotherapy as first-line treatment for advanced pancreati…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: IBI343 Combined With Chemotherapy in Advanced Pancreatic Cancer [Phase 2]
Phase 2 clinical trial evaluating IBI343 in combination with chemotherapy for advanced pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: A Study to Compare QLS31905 and Chemotherapy With Placebo and Chemotherapy in Participants With Pancreatic Cancer [Phase 3]
Phase 3 study to compare QLS31905 plus chemotherapy versus placebo plus chemotherapy in pancreatic cancer; the trial is currently recruiting…
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Monitoring and Managing Glucose Levels in People With Pancreatic Cancer [NA]
A Clinical Trial Update indicating that a study to monitor and manage glucose levels in people with pancreatic cancer is currently recruitin…
-
CLINICAL_TRIALS research · 2025-09-19Clinical Trial Update: Clinical Study of TQB2868 Injection Combined With Anlotinib Capsule and Chemotherapy in the First-line Treatment of Metastatic Pancreatic Neoplasms [Phase 2]
This Phase 2 clinical trial explores TQB2868 with Anlotinib and chemotherapy as first-line treatment for metastatic pancreatic cancer and is…
-
CLINICAL_TRIALS trial_result · 2025-09-19Clinical Trial Update: Study of IK-595 in RAS- or RAF-altered Advanced Tumors [Phase 1]
Phase 1 study of IK-595 in Ras- or Raf-altered advanced tumors has been terminated.
-
CLINICAL_TRIALS research · 2025-09-18Clinical Trial Update: A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 study of ERX-315 in patients with metastatic breast, ovarian, endometrial, liver, or pancreatic cancers is currently recruiting.